...
首页> 外文期刊>ACM Journal on Emerging Technologies in Computing Systems >Integrated Droplet Routing and Defect Tolerance in the Synthesis of Digital Microfluidic Biochips
【24h】

Integrated Droplet Routing and Defect Tolerance in the Synthesis of Digital Microfluidic Biochips

机译:数字微流控生物芯片合成中的集成液滴路由和缺陷容限

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Microfluidic biochips are revolutionizing high-throughput DNA sequencing, immunoassays, and clinical diagnostics. As high-throughput bioassays are mapped to digital microfluidic platforms, the need for design automation techniques is being increasingly felt. Moreover, as most applications of biochips are safety-critical in nature, defect tolerance is an essential system attribute. Several synthesis tools have recently been proposed for the automated design of biochips from the specifications of laboratory protocols. However, only a few of these tools address the problem of defect tolerance. In addition, most of these methods do not consider the problem of droplet routing in microfluidic arrays. These methods typically rely on postsynthesis droplet routing to implement biochemical protocols. Such an approach is not only time consuming, but also imposes an undue burden on the chip user. Postsynthesis droplet routing does not guarantee that feasible droplet pathways can be found for area-constrained biochip layouts; nonroutable fabricated biochips must be discarded. We present a synthesis tool that integrates defect tolerance and droplet routing in the design flow. Droplet routability, defined as the ease with which droplet pathways can be determined, is estimated and integrated in the synthesis procedure. Presynthesis and postsynthesis defect-tolerance methods are also presented. We use a large-scale protein assay as a case study to evaluate the proposed synthesis method.
机译:微流体生物芯片正在彻底改变高通量DNA测序,免疫测定和临床诊断方法。随着高通量生物测定被映射到数字微流控平台,对设计自动化技术的需求日益增长。此外,由于生物芯片的大多数应用本质上都是安全性至关重要的,因此缺陷容忍度是系统的基本属性。最近已经提出了几种合成工具,用于根据实验室规程的规范自动设计生物芯片。但是,这些工具中只有少数解决了容错的问题。另外,大多数这些方法没有考虑微流体阵列中的液滴路由问题。这些方法通常依赖于合成后的液滴路由来实施生化方案。这种方法不仅耗时,而且给芯片用户带来了不适当的负担。合成后的液滴路由不能保证能够为面积受限的生物芯片布局找到可行的液滴路径。不可处理的人造生物芯片必须丢弃。我们提出了一种综合工具,该工具在设计流程中集成了缺陷耐受性和墨滴布线。估计液滴的可路由性,定义为可以确定液滴路径的难易程度,并将其整合到合成过程中。还提出了合成前和合成后缺陷的容忍方法。我们使用大规模蛋白质分析作为案例研究来评估所提出的合成方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号